<DOC>
	<DOCNO>NCT00767624</DOCNO>
	<brief_summary>The aim propose three-site study increase rate full remission major depressive disorder ( MDD ) end 16 week treatment people experience major depressive disorder insomnia .</brief_summary>
	<brief_title>TRIAD - Treatment Insomnia Depression</brief_title>
	<detailed_description>Participants major depressive disorder insomnia meet study criterion receive state-of-the-art antidepressant medication one two insomnia therapy . The specific therapy insomnia determine chance ( like flip coin ) , equal chance receive either cognitive-behavioral therapy insomnia desensitization psychotherapy insomnia . The study physician select initial antidepressant medication list three possible medication . If medication helpful , another medication may try 8 week event severe side effect .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>1 . Meets criteria Major Depressive Disorder 2 . Between 18 75 year age adequately fluent English 3 . Meets criteria insomnia disorder 1 . Women currently pregnant , breastfeed , use reliable birth control method . 2 . People antidepressant medication ( ) provide study indicate 3 . People minimum adequate trial ( able tolerate ) three study medication . 4 . People uncontrolled medical condition . 5 . People moderate severe sleep disorder insomnia 6 . Individuals fix night shift rotate work schedule require night shift . 7 . Patients current principal diagnosis psychiatric disorder necessitates treatment offer study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>